
## **Trustees’ Annual Report for the period** 

## **From: 06.05.2022      Period start date   To: 05.04.2023            Period end date** 

## **Charity name: Pink Pants Trust** 

## **Charity registration number: 1172437** 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The main objective of The Pink Pants Trust is to<br>promote and to protect the good health of<br>sufferers and individuals at risk of Breast<br>and/or Ovarian Cancer.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|Charity events to promote Pink Pants Trust<br>work and to raise funds for the charity. Funded<br>4 BRCA gene tests and provided ongoing<br>support that were previously refused via the<br>NHS pathway. Provided intervention and direct<br>referrals to LRI genetics department to access<br>NHS testing.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|The trustees confirm that activities undertaken<br>were done so with regard to the commissions<br>public benefit guidance.|



## **Achievements and Performance** 

SORP reference 



|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|We continue to build awareness of our charity<br>within Leicestershire region with the general<br>public and local organisations. We have funded<br>4 individual BRCA gene tests whom has<br>approached our charity for support. We were<br>also able to intervene and support direct<br>testing with LRI after NHS funding was refused.<br>The university of hospitals genetic department<br>still have strong links to the Charity.|
|---|---|---|



## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|The charity does not have a reserves policy.|
|Details of fund materially in<br>deficit|Para 1.24||



## **Additional information (optional)** You may choose to include further statements where relevant about: 

|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47|The trusts principle sources of funding this year<br>have been raised through public fundraising.|
|---|---|---|
|Other||BRCA gene testing conducted directly meets<br>the trusts criteria on screening individuals, the<br>trust’s total expenditure for this year was £500.|





## **Reference and Administrative details** 

|Charity name|Pink Pants Trust|
|---|---|
|Other name the charity uses||
|Registered charity number|1172437|
|Charity’s principal address|36 Cadle Close<br>Stoney Stanton<br>Leicester<br>LE9 4WH|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year **|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Julie Chapman|||SallyChapman|
||Sarah Vakilpour|||SallyChapman|
||Rachael Goody|||SallyChapman|
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

|**Signature(s**<br>**Full name(s**<br>**Position (eg Secretary,**<br>**Chair, etc)**<br>**Date**|**)**J Chapman<br>**)**Julie Chapman<br> <br> <br>Treasurer<br>31.01.2023||
|---|---|---|
||||
||||





||**The Pink Pants Trust**<br>|**The Pink Pants Trust**<br>|**The Pink Pants Trust**<br>|**No (if any)**|**CC16a**|
|---|---|---|---|---|---|
||**For the period**<br>**from**|4/6/2022|**To**|4/5/2023||
|||||||
|**Section A Receipts and payments**||||||
|**A1 Receipts**<br>Fund Raising<br>**1,152**<br>Interest<br>**38**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,190**<br>**-**<br>**-**<br>**_Sub total_                              -**<br>**_Total receipts_                   1,190**<br>**A3 Payments**<br>Website - new<br>**740**<br>Website MonthlyFee<br>**270**<br>BRCA Testing<br>**301**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                       1,311**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total payments_                   1,311**<br>**_Net of receipts/(payments)_ -                    121**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**15,160**<br>**_Cash funds this year end_                 15,039**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**||**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**<br>**1,152**<br>**38**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,190**<br>**-**<br>**-**<br>**-**<br>**1,190**<br>**740**<br>**270**<br>**301**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**1,311**<br>**-**<br>**-**<br>**-**<br>**1,311**<br>**-                    121**<br>**-**<br>**15,160**<br>**15,039**|**Last year**<br>**to the nearest £**|
||||**-**|**1,152**|**-**|
||||**-**|**38**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**1,190**|**-**|
|||||||
||||**-**|**-**||
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
|||||||
||||**-**|**1,190**|**-**|
|||||||
||||**-**|**740**|**-**|
||||**-**|**270**|**-**|
||||**-**|**301**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**-**|**-**|
||||**-**|**1,311**|**-**|
|||||||
||||**-**|**-**||
||||**-**|**-**||
||||**-**|**-**|**-**|
|||||||
||||**-**|**1,311**|**-**|
|||||||
|||**-**|**-**|**-                    121**|**-**|
|||**-**|**-**|**-**|**-**|
|||**-**|**-**|**15,160**|**-**|
|||**-**|**-**|**15,039**|**-**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>J.Chapman<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**15,039**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**15,039**<br>**-**<br>OK<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Julie Chapman<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||J.Chapman|Julie Chapman|31.01.2024|
|||||



